ベンダー
English
search
  2. //
  3. Celent news
  4. //
  5. What exactly to make of PCR 'doubling' assets to $250B in an eye-blink...

What exactly to make of PCR 'doubling' assets to $250B in an eye-blink...

Website
Create a vendor selection project
Click to express your interest in this report
Indication of coverage against your requirements
A subscription is required to activate this feature. Contact us for more info.
Celent have reviewed this profile and believe it to be accurate.
We are waiting for the vendor to publish their solution profile. Contact us or request the RFX.
Projects allow you to export Registered Vendor details and survey responses for analysis outside of Marsh CND. Please refer to the Marsh CND User Guide for detailed instructions.
Download Registered Vendor Survey responses as PDF
Contact vendor directly with specific questions (ie. pricing, capacity, etc)
2018/03/13

Will Trout: I find it hard to believe that PCR could attempt to replicate Addepar's attempts to map and aggregate the entire investments ecosystem. I'm skeptical of Addepar's progress already

詳細はこちら

記事 details

Industry
Wealth Management
Media Type
Newsletters
Geographic Focus
Asia-Pacific, EMEA, LATAM, North America